PMID- 36915878 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230315 IS - 2223-4691 (Print) IS - 2223-4691 (Electronic) IS - 2223-4683 (Linking) VI - 12 IP - 2 DP - 2023 Feb 28 TI - Lycopene alleviates lipopolysaccharide-induced testicular injury in rats by activating the PPAR signaling pathway to integrate lipid metabolism and the inflammatory response. PG - 271-285 LID - 10.21037/tau-22-864 [doi] AB - BACKGROUND: Male fertility can be hampered by systemic and testicular infections and inflammation, which can lead to impaired spermatogenesis that often cannot be reversed by antibiotic treatment. There has been some suggestion that lycopene (LYC) may be useful in the preservation of fertility, although its mechanisms are complex. This current study examined the therapeutic efficacy of LYC on testicular damage and its underlying mechanisms. METHODS: Lipopolysaccharide (LPS; 5 mg/kg) was injected intraperitoneally to induce inflammation of the testes in mature male rats. The rats in the experimental group were administered 5 mg/kg LYC intragastrically for 4 weeks. The testes were harvested from the euthanized rats for lipidomics, RNA sequencing, and related experimental tests. RESULTS: Laboratory data suggested that LPS-induced systemic inflammation induced cytokine excess and oxidative stress in the testes. Administration of oral LYC inhibited the excess cytokine production and oxidative stress, mitigating damage to the testes. Lipidomic studies identified significant changes to 258 lipids and 5 metabolism pathways. Coupled with RNA sequencing analysis, 1,116 genes were found to be significantly regulated and many lipid metabolism-related signaling pathways were identified. The expression of retinoid X receptor alpha (RXR) in the peroxisome proliferator-activated receptor (PPAR) signaling pathway was significantly upregulated after LYC treatment, which activated the RXR/PPAR easy dimer. The expression of downstream genes such as fatty acid binding protein 3 (FABP3) and carnitine palmitoyltransferase 1A (CPT1A) was increased. These genes are involved in the control of fatty acid metabolism, fatty acid degradation, fatty acid chain elongation, and lipid metabolism, which partially explains the changes in the content and composition of lipids. CONCLUSIONS: LYC regulates the lipid metabolism of testes and lipid metabolism-related signaling pathways, such as the PPAR signaling pathway. Furthermore, LYC ameliorated the LPS-induced dysregulation of lipid metabolism in the testes, as well as the LPS-induced inflammatory response. This study offers a new perspective for the investigation of the mechanisms in inflammatory testicular damage and potential therapeutic targets. CI - 2023 Translational Andrology and Urology. All rights reserved. FAU - Li, Yu AU - Li Y AD - Department of Urology, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing, China. FAU - Zhan, Mingwei AU - Zhan M AD - Department of Urology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China. FAU - Li, Jindong AU - Li J AD - Department of Urology, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing, China. AD - Central South University Xiangya School of Medicine Affiliated Haikou Hospital, Haikou, China. FAU - Zhang, Wei AU - Zhang W AD - Department of Urology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China. FAU - Shang, Xuejun AU - Shang X AD - Department of Urology, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing, China. AD - Department of Urology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China. LA - eng PT - Journal Article DEP - 20230215 PL - China TA - Transl Androl Urol JT - Translational andrology and urology JID - 101581119 PMC - PMC10006007 OTO - NOTNLM OT - Transcriptome OT - inflammatory infertility OT - lipidomics OT - oxidative stress OT - testis COIS- Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-22-864/coif). The authors have no conflicts of interest to declare. EDAT- 2023/03/15 06:00 MHDA- 2023/03/15 06:01 PMCR- 2023/02/28 CRDT- 2023/03/14 02:14 PHST- 2022/12/01 00:00 [received] PHST- 2023/02/06 00:00 [accepted] PHST- 2023/03/14 02:14 [entrez] PHST- 2023/03/15 06:00 [pubmed] PHST- 2023/03/15 06:01 [medline] PHST- 2023/02/28 00:00 [pmc-release] AID - tau-12-02-271 [pii] AID - 10.21037/tau-22-864 [doi] PST - ppublish SO - Transl Androl Urol. 2023 Feb 28;12(2):271-285. doi: 10.21037/tau-22-864. Epub 2023 Feb 15.